首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease
【24h】

Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease

机译:含甲硝唑的新型粘膜粘膜颊粘膜制剂可用于治疗牙周疾病

获取原文
获取原文并翻译 | 示例
           

摘要

Mucoadhesive tablets using different mixture of cellulose and polyacrylic derivatives were prepared in order to obtain new formulations containing metronidazole for periodontal disease treatment. All tablets were characterized by swelling studies, ex vivo and in vivo mucoadhesive time, ex vivo mucoadhesion force, in vitro and in vivo release. The best mucoadhesive performance and the best in vitro drug release profile were achieved by using hydroxyethyl cellulose (HEC) and carbomer 940 2:2 ratio. The chosen tablet, containing 20 mg of metronidazole, performed 12 h drug sustained release with buccal concentrations always higher than its MIC. (C) 2004 Elsevier B.V. All rights reserved.
机译:制备使用纤维素和聚丙烯酸酯衍生物的不同混合物的粘膜粘着剂片剂,以获得用于治疗牙周疾病的含有甲硝唑的新制剂。所有片剂的特征在于溶胀研究,离体和体内粘膜粘附时间,离体粘膜粘附力,离体和体内释放。通过使用羟乙基纤维素(HEC)和卡波姆940 2:2的比例,可以获得最佳的粘膜粘附性能和最佳的体外药物释放曲线。所选择的含有20毫克甲硝唑的片剂可以持续12小时药物缓释,其颊浓度始终高于其MIC。 (C)2004 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号